Clinical Trials on Hypersensitivity, Delayed in South Africa
Total 3144 results
-
Bristol-Myers SquibbEisai Inc.RecruitingNeoplasms, OvarianAustralia, United States, Korea, Republic of, Chile, Belgium, Italy, Spain, Israel, Japan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Neurotoxicity | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Ovarian Carcinoma | Endometrioid Adenocarcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States, Spain
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Peru, Spain, United Kingdom, India, Philippines, Russian Federation, Hong Kong
-
Vertex Pharmaceuticals IncorporatedCompletedDiabetic Peripheral NeuropathyUnited States
-
Verastem, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingLow Grade Serous Ovarian CancerUnited States, Australia
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Mexico, Japan, Serbia, Turkey, Italy, Czechia, Bulgaria, Algeria, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Puerto Rico, Germany, Turkey, Canada, Bulgaria
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian CarcinomaUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States
-
TakedaTerminatedHypertension | DiabetesUnited States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Sweden, Latvia, Finland, Greece, Romania, Czechia, Puerto Rico
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End Stage Kidney DiseaseUnited States, Bulgaria, Portugal, Spain, Serbia, Poland
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingGlioma | Cholangiocarcinoma | Chondrosarcoma | Any Solid TumorUnited States, Spain, Korea, Republic of, Australia, Japan, Taiwan, France, Singapore, Hong Kong
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, Chile, Czech Republic, India, Peru, Poland
-
PfizerTerminatedAvelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid TumorsUnited States, Canada, United Kingdom, Korea, Republic of, Australia, Belgium, Denmark, Hungary, Russian Federation
-
VA Office of Research and DevelopmentRecruiting
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
-
Natera, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedAneuploidy | Trisomy 21 | Trisomy 18 | Trisomy 13United States, Ireland, Canada, Italy, Korea, Republic of, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Puerto Rico, Canada, Denmark, France, Austria, Taiwan, Czechia, Brazil, China, Argentina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Canada, Spain, Switzerland, Argentina, Finland, Hungary, Russian Federation, Slovenia, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, Italy, Poland, Russian Federation, Spain, Greece, Serbia, Thailand, Brazil, Hungary, Argentina
-
NewLink Genetics CorporationCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, United Kingdom, Belgium, Norway, Germany, Greece
-
Akros Pharma Inc.CompletedType II Diabetes MellitusUnited States, Russian Federation, Czech Republic, Hungary, Netherlands
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingCardiotoxicity | Recurrent Breast Carcinoma | HER2/Neu Positive | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7United States, Korea, Republic of, Puerto Rico, Saudi Arabia
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
Applied Therapeutics, Inc.Active, not recruitingDiabetic CardiomyopathiesUnited States, France, Spain, Australia, Canada, United Kingdom, Germany, Czechia, Hong Kong, Poland
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Eli Lilly and CompanyCompletedObesity | OverweightUnited States, Taiwan, Argentina, Brazil, Puerto Rico
-
Auspex Pharmaceuticals, Inc.CompletedTardive DyskinesiaUnited States, Czechia, Germany, Hungary, Poland, Slovakia
-
Eli Lilly and CompanyRecruitingObesity | Overweight | Obstructive Sleep Apnea | Type 2 DiabetesAustralia, United States, Mexico, Spain, India, Brazil, Romania, Taiwan, Argentina
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Halozyme TherapeuticsCompletedMetastatic Pancreatic AdenocarcinomaUnited States
-
Novo Nordisk A/SCompleted
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Ukraine, Argentina, Bulgaria, Hungary, Slovakia, Guatemala, Mexico
-
Bristol-Myers SquibbTerminatedDiabetic Kidney DiseaseUnited States, Canada, Denmark, France
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Neurotoxicity | Peripheral NeuropathyUnited States
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Mexico, Guatemala
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Serbia, Turkey, Russian Federation, India, Latvia, Puerto Rico, Lebanon, Colombia
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightUnited States, Taiwan, India, China, Mexico, Brazil, Puerto Rico, Japan, Argentina, Russian Federation
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Genentech, Inc.; AllerganCompletedDiabetic Retinopathy | Diabetic Macular EdemaUnited States